Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sino Biopharmaceutical Limited
  6. Financials
    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 64 960136 693140 925124 518--
Entreprise Value (EV)1 61 143131 372139 416114 675109 728102 818
P/E ratio 6,03x46,2x42,6x20,2x20,2x17,6x
Yield 1,55%0,73%1,07%1,25%1,26%1,47%
Capitalization / Revenue 2,66x5,16x4,99x3,63x3,00x2,55x
EV / Revenue 2,50x4,96x4,94x3,35x2,64x2,11x
EV / EBITDA 9,88x18,8x20,3x13,3x10,8x8,32x
Price to Book 1,90x4,04x7,07x4,76x3,44x3,13x
Nbr of stocks (in thousands) 18 883 80218 810 95618 789 99918 781 019--
Reference price (HKD) 3,447,277,506,636,636,63
Announcement Date 03/31/201903/30/202003/23/2021---
1 HKD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 24 43126 47328 22134 26141 53348 812
EBITDA1 6 1876 9906 8798 65310 20512 360
Operating profit (EBIT)1 4 7715 2874 8917 0358 6309 874
Operating Margin 19,5%20,0%17,3%20,5%20,8%20,2%
Pre-Tax Profit (EBT)1 13 3686 1005 98310 58511 16412 952
Net income1 10 5812 9573 3076 2326 4187 385
Net margin 43,3%11,2%11,7%18,2%15,5%15,1%
EPS2 0,570,160,180,330,330,38
Dividend per Share2 0,050,050,080,080,080,10
Announcement Date 03/31/201903/30/202003/23/2021---
1 HKD in Million
2 HKD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 6 4556 5898 7418 9528 8507 120
EBITDA ------
Operating profit (EBIT)1 --1 4991 7721 933646
Operating Margin --17,2%19,8%21,8%9,07%
Pre-Tax Profit (EBT) -1 519----
Net income -1 099----
Net margin -16,7%----
EPS2 0,000,060,110,130,110,05
Dividend per Share ------
Announcement Date 11/30/202003/23/202105/24/2021---
1 HKD in Million
2 HKD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 3 8175 3211 5099 84314 79021 700
Leverage (Debt / EBITDA) -0,62x-0,76x-0,22x-1,14x-1,45x-1,76x
Free Cash Flow1 3 9623 4794 4757 1297 0509 027
ROE (Net Profit / Equities) 14,8%8,97%17,5%26,2%21,1%20,5%
Shareholders' equity1 71 53932 94918 90823 81930 44236 096
ROA (Net Profit / Asset) 8,04%5,01%6,54%11,0%10,6%12,2%
Assets1 131 66859 03350 56656 88260 56460 439
Book Value Per Share2 1,811,801,061,391,932,12
Cash Flow per Share2 0,310,310,340,400,490,59
Capex1 1 9802 3391 8862 0972 2182 431
Capex / Sales 8,10%8,84%6,68%6,12%5,34%4,98%
Announcement Date 03/31/201903/30/202003/23/2021---
1 HKD in Million
2 HKD
Key data
Capitalization (HKD) 124 518 154 179
Capitalization (USD) 16 021 048 741
Net sales (HKD) 28 220 740 660
Net sales (USD) 3 629 441 236
Number of employees 24 262
Sales / Employee (HKD) 1 163 166
Sales / Employee (USD) 149 594
Free-Float 52,4%
Free-Float capitalization (HKD) 65 242 317 234
Free-Float capitalization (USD) 8 394 361 057
Avg. Exchange 20 sessions (HKD) 406 839 488
Avg. Exchange 20 sessions (USD) 52 323 220
Average Daily Capital Traded 0,33%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA